Protecting Patients from Deceptive Drug Ads Online Act Introduced

Senators Dick Durbin of Illinois and Mike Braun of Indiana recently introduced bipartisan legislation aimed at closing regulatory loopholes by having the Food and Drug Administration (FDA) address false and misleading prescription drug promotions by social media influencers and telehealth companies, the Protecting Patients from Deceptive Drug Ads Online Act.

The FDA is responsible for ensuring that promotions by manufacturers are accurate, that risks and benefits are properly disclosed, and that the information on the FDA-approved label is shared with consumers. However, when it comes to influencers and telehealth companies, there is currently a gap in FDA’s oversight and there are many such promotions that provide false information, leave out key side effects, or generate demand for medications that...

Today's Sponsors

Today's Sponsor